Source: Virtual Congress 2020 – Smoking disease landscape: from inflammation to lung function and comorbidities
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Imen (Mahdia, Tunisia), B. Soumaya (Mahdia, Tunisia), K. Nadia (Mahdia, Tunisia), B. Mohamed Amine (Mahdia, Tunisia), N. Elaa (Mahdia, Tunisia), R. Raja (Mahdia, Tunisia), B. Chaima (Mahdia, Tunisia), K. Jalel (Mahdia, Tunisia), B. Leila (Mahdia, Tunisia). Systemic inflammation in COPD in relation to smoking status. 1325

Member's Comments

No comment yet.

Related content which might interest you: Relation between physical capacity, nutritional status and systemic inflammation in COPD patients Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates Year: 2008 Systemic inflammation and nutritive status in patients with COPD Source: Annual Congress 2011 - COPD mechanisms Year: 2011 CD8+ve airway inflammation in COPD: The impact of smoking status Source: Annual Congress 2003 - Cigarette smoke: how it does its dirty work Year: 2003 Pulmonary function in smoking and systemic inflammation Source: Annual Congress 2009 - Tobacco: from smoke to disease Year: 2009 Systemic inflammatory response in relation to disease severity and nutritional depletion in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 31s Year: 2004 Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis Source: Eur Respir J 2007; 30: 467-471 Year: 2007 Systemic manifestations in smokers and mild/moderate chronic obstructive pulmonary disease Source: International Congress 2015 – Best abstracts in COPD management Year: 2015 Inflammation in COPD: a link to systemic comorbidities Source: Eur Respir Rev 2007; 16: 91-97 Year: 2007 The relationship between comorbidities and systemic inflammation in patients with COPD Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Chronic mucus hypersecretion in asthma: Relation to smoking status and disease severity Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 The tobacco smoking influence on parodontic inflammation in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 167s Year: 2007 Smoking, systemic inflammation and pulmonary function Source: Eur Respir J 2006; 28: Suppl. 50, 248s Year: 2006 Influence of smoking on airway and systemic inflammation in healthy subjects and COPD patients Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 The effect of smoking on the activity of inflammatory markers in patients with COPD Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease Year: 2013 Influence of active smoking on systemic TNF-α concentration in COPD patients Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 Relationship between asthma and systemic inflammation Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung Year: 2010 COPD patients‘ response to smoking cessation Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results Year: 2005 COPD disease progression and airway inflammation: uncoupled by smoking cessation Source: Eur Respir J 2005; 26: 764-766 Year: 2005 Duration of smoking cessation and bronchial inflammation in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 459s Year: 2004 The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation Source: Eur Respir J 2004; 23: 464-476 Year: 2004